Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Revenue

Kymera Therapeutics had revenue of $3.74M in the quarter ending September 30, 2024, a decrease of -20.88%. This brings the company's revenue in the last twelve months to $87.56M, up 86.92% year-over-year. In the year 2023, Kymera Therapeutics had annual revenue of $78.59M with 67.84% growth.

• Revenue (ttm): $87.56M
• Revenue Growth: +86.92%
• P/S Ratio: 35.03
• Revenue / Employee: $468,251
• Employees: 187
• Market Cap: 2.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	78.59M	31.77M	67.84%
Dec 31, 2022	46.83M	-26.01M	-35.71%
Dec 31, 2021	72.83M	38.80M	114.00%
Dec 31, 2020	34.03M	31.10M	1,059.99%
Dec 31, 2019	2.93M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.